Gender-Affirming Hormone Therapy Tied to Systolic BP Changes

MONDAY, April 19, 2021 -- Within two to four months of starting gender-affirming hormone therapy (GAHT), transfeminine adults have lower mean systolic blood pressure and transmasculine adults have higher mean systolic blood pressure, according to a...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news